- Home
- JD vs GEHC Comparison
JD vs GEHC Comparison
Compare JD & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JD | GEHC |
|---|---|---|
| Founded | 2006 | 1892 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Computer Software: Prepackaged Software |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.7B | 38.9B |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | JD | GEHC |
|---|---|---|
| Price | $28.78 | $79.63 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 11 |
| Target Price | $41.10 | ★ $88.27 |
| AVG Volume (30 Days) | ★ 9.5M | 3.1M |
| Earning Date | 03-05-2026 | 02-04-2026 |
| Dividend Yield | ★ 3.52% | 0.18% |
| EPS Growth | N/A | ★ 32.35 |
| EPS | 2.99 | ★ 4.83 |
| Revenue | ★ $183,136,729,092.00 | $20,246,000,000.00 |
| Revenue This Year | $15.62 | $6.33 |
| Revenue Next Year | $5.48 | $4.32 |
| P/E Ratio | ★ $9.50 | $16.32 |
| Revenue Growth | ★ 16.63 | 3.51 |
| 52 Week Low | $28.21 | $57.65 |
| 52 Week High | $46.45 | $94.80 |
Technical Indicators
Market Signals| Indicator | JD | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 43.84 | 40.47 |
| Support Level | $28.34 | $78.31 |
| Resistance Level | $30.98 | $87.60 |
| Average True Range (ATR) | 0.64 | 2.29 |
| MACD | -0.05 | -0.92 |
| Stochastic Oscillator | 16.48 | 12.22 |
Price Performance
Historical ComparisonAbout JD JD.com Inc.
JD.com is the third-largest Chinese e-commerce platform by gross merchandise volume in 2024. it offers a wide selection of authentic products with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace and omnichannel businesses.
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).